# Pliant Therapeutics (PLRX) — Earnings

PLRX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/plrx/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$0.71 |
| EPS estimate | −$0.68 |
| EPS surprise | −4.84% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Aug 7, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1746473/000174647325000150/plrx-20250630.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Aug 7, 2025 | −$0.68 | −$0.71 | -4.84% | — | — |
| Q1 2025 | May 8, 2025 | −$0.77 | −$0.92 | -19.98% | — | — |
| Q4 2024 | Mar 3, 2025 | −$0.96 | −$0.82 | 14.26% | — | — |
| Q3 2024 | Nov 7, 2024 | −$0.97 | −$0.95 | 1.98% | $472,222.00 | — |
| Q2 2024 | Aug 7, 2024 | −$0.85 | −$0.92 | -8.41% | $732,500.00 | — |
| Q1 2024 | May 6, 2024 | −$0.77 | −$0.78 | -1.06% | $580,625.00 | — |
| Q4 2023 | Feb 27, 2024 | −$0.81 | −$0.69 | 15.18% | $814,114.00 | — |
| Q3 2023 | Nov 9, 2023 | −$0.78 | −$0.70 | 9.71% | $1.0M | — |
| Q2 2023 | Aug 9, 2023 | −$0.71 | −$0.70 | 1.85% | $1.2M | $248,000.00 |
| Q1 2023 | May 9, 2023 | −$0.67 | −$0.67 | -0.25% | $1.4M | $1.3M |
| Q4 2022 | Mar 9, 2023 | −$0.70 | −$0.72 | -2.86% | $1.5M | $2.0M |
| Q3 2022 | Nov 8, 2022 | −$0.74 | −$0.65 | 12.30% | $1.8M | $1.5M |
| Q2 2022 | Aug 8, 2022 | −$0.81 | −$0.82 | -0.94% | $1.3M | $5.0M |
| Q1 2022 | May 9, 2022 | −$0.75 | −$0.78 | -4.08% | $1.3M | $1.2M |
| Q4 2021 | Feb 28, 2022 | −$0.76 | −$0.68 | 10.61% | $3.0M | $2.0M |
| Q3 2021 | Nov 9, 2021 | −$0.69 | −$0.75 | -8.63% | $3.2M | $1.6M |
| Q2 2021 | Aug 9, 2021 | −$0.67 | −$0.64 | 4.51% | $4.2M | $1.8M |
| Q1 2021 | May 10, 2021 | −$0.60 | −$0.64 | -5.84% | $4.2M | $2.2M |
| Q4 2020 | Mar 16, 2021 | −$0.71 | −$0.54 | 24.20% | $3.4M | $4.5M |
| Q3 2020 | Nov 10, 2020 | −$0.85 | −$0.47 | 44.61% | $2.5M | $4.8M |

## Frequently Asked Questions

### When did Pliant Therapeutics (PLRX) last report earnings?

Pliant Therapeutics last reported on Aug 7, 2025, covering fiscal Q2 2025.

### Did PLRX beat earnings estimates?

No. Pliant Therapeutics reported EPS of −$0.71 for Q2 2025 against a −$0.68 estimate — a 4.84% miss.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).